People with Omicron are significantly less likely to develop severe symptoms, but the effects of the booster vaccine wane after 10 weeks, according to new analysis by the UK Health Security Agency (UKHSA).
They are also 50 to 70% less likely to be admitted to hospital.
The findings are broadly similar to estimates calculated by researchers in Scotland and Imperial College London on Wednesday.
COVID-19: Omicron up to 70% less likely to lead to hospital admission than Delta but effectiveness of booster jabs waning for some, says UKHSA
They are also 50 to 70% less likely to be admitted to hospital.
The findings are broadly similar to estimates calculated by researchers in Scotland and Imperial College London on Wednesday.
COVID-19: Omicron up to 70% less likely to lead to hospital admission than Delta but effectiveness of booster jabs waning for some, says UKHSA
